NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
2.150
-0.060 (-2.71%)
At close: Apr 28, 2026, 4:00 PM EDT
2.128
-0.022 (-1.01%)
After-hours: Apr 28, 2026, 6:45 PM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $8.95 million as of April 28, 2026. Its market cap has increased by 118.24% in one year.
Market Cap
8.95M
Enterprise Value
-22.78M
1-Year Change
118.24%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $8.95M, a decrease of -98.26%. That is a compound annual growth rate of -37.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 9.20M | -38.67% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kiora Pharmaceuticals | 10.18M |
| Enveric Biosciences | 10.13M |
| Aprea Therapeutics | 9.86M |
| Quoin Pharmaceuticals | 9.85M |
| Evogene | 9.67M |
| Bolt Biotherapeutics | 9.53M |
| CalciMedica | 9.29M |
| Liminatus Pharma | 9.09M |